Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
959.4 INR | -0.03% | +1.55% | +39.21% |
11:12am | Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator | MT |
Apr. 22 | Zydus Arm Get UK Drug Regulator's Marketing Approval for Nulibry as MoCD Type A Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.21% | 11.58B | |
+17.88% | 44.31B | |
+19.87% | 22.17B | |
+14.97% | 14.62B | |
+8.06% | 13.12B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B | |
-1.14% | 4.27B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Cadila Healthcare : Gets US FDA Nod for Breast Cancer Treatment Drug